Total Funding
33
68
Total FundingSeries B raised
Growth Score
-13 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
78887
Next&Bio is a company that provides researchers and consumers with a new concept of medicine and pharmacy based on original technology.
Lee Hyun-sook: CEO
About the Company
Next&Bio is a biotechnology company developing organoid-based platforms for personalized medicine and drug screening. It uses patient-derived 3D cell models to support customized cancer treatment discovery and precision therapeutics. The company focuses on building advanced preclinical testing systems and collaborative research for drug
development, aiming to improve accuracy in disease modeling and accelerate next-generation biomedical innovation.
